Table 2.
Functioning at baseline (0 month) and at the six-month follow-up (6 months) together with predicted change in functioning (LMM). In LMM with a random subject effect, treatment (FIMA vs. usual care), time (0 vs. 6 months), and sex served as factors, and age and CCI (excluding dementia) at baseline served as covariates. Values at 0 month and 6 months indicate crude mean ± SD, predicted values indicate mean, 95% CI. P-values refer to the treatment-time-sex interaction
| FIMA | Usual Care | P | |||||
|---|---|---|---|---|---|---|---|
| 0 month | 6 months | LMM | 0 month | 6 months | LMM | ||
| ADL | 4.98 ± 1.30 | 4.71 ± 1.49 | −0.30, −0.32-(−0.28) | 4.82 ± 1.27 | 4.78 ± 1.37 | −0.09, −0.09-(− 0.09) | 0.026 |
| IADL | 4.05 ± 2.01 | 3.73 ± 2.11 | − 0.34, − 0.35-(− 0.34) | 4.05 ± 2.06 | 4.00 ± 2.14 | − 0.12, − 0.13-(− 0.11) | 0.217 |
| TUG, s | 28.6 ± 28.2 | 26.6 ± 22.3 | −0.98, −1.03-(− 0.93) | 25.5 ± 15.9 | 26.6 ± 17.7 | 2.35, 2.24–2.47 | 0.135 |
| MMSE | 22.4 ± 4.59 | 22.2 ± 4.84 | −0.39, − 0.41-(− 0.37) | 22.7 ± 4.68 | 22.5 ± 4.64 | −0.24, − 0.28-(− 0.20) | 0.194 |
| GDS-15 | 5.43 ± 3.20 | 5.27 ± 3.18 | −0.10, − 0.14-(− 0.05) | 4.95 ± 3.10 | 5.00 ± 3.03 | 0.14, 0.13–0.14 | 0.121 |
| EQ-5D-3L | 0.58 ± 0.25 | 0.57 ± 0.29 | −0.017, − 0.019-(− 0.016) | 0.59 ± 0.25 | 0.56 ± 0.27 | −0.023, − 0.026-(− 0.020) | 0.589 |
LMM Linear Mixed Models, FIMA The Finnish Interprofessional Medication Assessment, ADL Katz index of Activities of Daily Living, IADL Lawton and Brody scale of Instrumental Activities of Daily Living, TUG Timed up and go test MMSE Mini-Mental State Examination, GDS-15 Geriatric depression scale, EQ-5D-3L Health-related quality of life